Week of 2026-08-17

One hundred trades were disclosed this week, dominated by a sweeping portfolio reshuffle from Rep. Ro Khanna and a wave of filings arriving hundreds of days past the legal deadline.

The Big Picture

This week's disclosures cover 100 trades across both parties, with Democrats accounting for 71 and Republicans for 29. Technology was the most active sector on both the buy and sell sides, reflecting broad reshuffling rather than a clear directional bet. The week was also notable for the volume of severely late filings — several members disclosed transactions from 2024 and early 2025 that were hundreds of days beyond the 45-day statutory window.

This Week's Notable Trades

Ro Khanna (D-CA)

Bought a $100,001–$250,000 position in The Toronto-Dominion Bank (TD) corporate bond on July 16 — the week's second-largest disclosed transaction, reflecting an addition to fixed-income holdings alongside an otherwise equity-heavy week.
Bought $15,001–$50,000 positions in ServiceNow Inc (NOW), Texas Instruments Inc (TXN), Intercontinental Exchange Inc (ICE), Bank of America Corp (BAC), and Marvell Technology Inc (MRVL) on July 7 — the California Democrat's 66-trade disclosure batch this week spans technology, healthcare, financials, industrials, and consumer stocks.
Sold $15,001–$50,000 positions in salesforce.com Inc (CRM), Autodesk Inc (ADSK), and The TJX Companies Inc (TJX) on July 7 — trimming prior positions in enterprise software and retail even as he added to other technology names.
Potential conflict: Rep. Khanna serves on the House Armed Services Committee. Several of his disclosed trades involve industrials companies — including Builders FirstSource Inc (BLDR), Illinois Tool Works Inc (ITW), Ingersoll Rand Inc (IR), EMCOR Group Inc (EME), Eaton Corp PLC (ETN), Johnson Controls International PLC (JCI), Xylem Inc (XYL), Copart Inc (CPRT), and FedEx Corp (FDX) — whose sectors overlap with that committee's jurisdiction over defense procurement and industrial contracting.

Shri Thanedar (D-MI)

Sold a $100,001–$250,000 position in Apple Inc (AAPL) — a trade dated January 9, 2026 and disclosed August 14, some 217 days after the transaction. This was the single largest trade by dollar range disclosed this week.
Sold a $15,001–$50,000 position in MicroStrategy Inc (MSTR) from October 21, 2025, disclosed 297 days late. MicroStrategy is a software company that holds a large reserve of Bitcoin, making its stock price closely tied to cryptocurrency markets.

Carol Devine Miller (R-WV)

Sold a $15,001–$50,000 position in Pfizer Inc (PFE) and a $15,001–$50,000 position in Quest Diagnostics Inc (DGX) — both transactions dated March 10, 2025 and disclosed 522 days after the trades. Quest Diagnostics is a medical laboratory testing company.
Also disclosed same-day sales of Target Corp (TGT) ($15,001–$50,000) and U.S. Bancorp (USB) ($15,001–$50,000), each from March 10, 2025 and also 522 days overdue.
Potential conflict: Rep. Miller serves on the House Ways and Means Committee, which has jurisdiction over Medicare and Medicaid policy. Her disclosed sales of Pfizer Inc (PFE) and Quest Diagnostics Inc (DGX) represent a potential overlap between that committee's healthcare policy role and the healthcare sector.

Charles J. "Chuck" Fleischmann (R-TN)

Bought a $15,001–$50,000 position in the SPDR Bloomberg Barclays Intermediate Term Treasury ETF (SPTI) on July 28, a fund holding U.S. Treasury bonds with roughly three-to-ten-year maturities, while simultaneously selling a $15,001–$50,000 position in the iShares 10-20 Year Treasury Bond ETF (TLH) — a move that shortens the duration of his government bond exposure.
Reduced commodity-related holdings, selling the SPDR Gold MiniShares (GLDM) and VanEck Gold Miners ETF (GDX), while adding international equity exposure through the iShares Core MSCI Europe ETF (IEUR) and Vanguard FTSE Pacific ETF (VPL).
Also sold the Global X Defense Tech ETF (SHLD) ($1,001–$15,000) and the SPDR Portfolio S&P 500 Growth ETF (SPYG) ($1,001–$15,000) while buying smaller positions in the ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) and the Invesco S&P SmallCap Quality ETF (XSHQ) — a pattern suggesting a rotation away from growth and gold toward income-oriented and international funds.

Tracey Robert Mann (R-KS)

Bought $1,001–$15,000 positions in Alphabet Inc (GOOGL), NVIDIA Corporation (NVDA), Apple Inc (AAPL), Microsoft Corp (MSFT), and Meta Platforms Inc (META) — all dated August 20, 2024 and disclosed 724 days after the transactions, nearly two years past the legal deadline.
Sold the same group of large-cap technology stocks in September 2024, with those disclosures arriving 704 days late — together the ten filings describe a brief round-trip into major tech names that the public is only learning about now.

Mike Kelly (R-PA)

Sold a $15,001–$50,000 position in PepsiCo Inc (PEP) on July 17, along with smaller positions in The Walt Disney Co (DIS) and Abbott Laboratories (ABT) on the same date — all disclosed within 26 days of the trades, well within the statutory window.
Potential conflict: Rep. Kelly serves on the House Ways and Means Committee. His disclosed sale of Abbott Laboratories (ABT), a medical devices and pharmaceutical company, represents a potential overlap between that committee's jurisdiction over healthcare financing policy and the healthcare sector.

By the Numbers

Total trades disclosed this week: 100
Party split: Democrats, 71 trades; Republicans, 29 trades
Most purchased sector: Technology (18 trades); most sold sector: Technology (11 trades), with Healthcare second on the sell side (7 trades)
Most active member: Rep. Ro Khanna (D-CA), with 66 disclosed trades
Potential conflicts flagged: 14

Most significant potential conflicts this week:

Rep. Carol Devine Miller (R-WV, Ways and Means) — sold Pfizer Inc (PFE) and Quest Diagnostics Inc (DGX), both healthcare companies, while the committee oversees Medicare and Medicaid
Rep. Mike Kelly (R-PA, Ways and Means) — sold Abbott Laboratories (ABT), a healthcare company, under the same committee jurisdiction
Rep. Kevin Hern (R-OK, Ways and Means) — sold Organon & Co (OGN), a pharmaceutical company, also under Ways and Means
Rep. Ro Khanna (D-CA, Armed Services) — disclosed trades in nine industrials companies, including EMCOR Group, Eaton Corp, and FedEx Corp, whose sectors overlap with the committee's defense and procurement oversight

Late to File

Under the STOCK Act, members must disclose a trade within 45 days. This week's batch included some of the most delayed filings seen in recent weeks.

Rep. Tracey Robert Mann (R-KS) disclosed ten trades all at once — Alphabet Inc (GOOGL), 724 days late; NVIDIA Corporation (NVDA), 724 days late; Apple Inc (AAPL), 724 days late; Microsoft Corp (MSFT), 724 days late; Meta Platforms Inc (META), 724 days late; and the same five stocks sold in September 2024, each disclosed 704 days after the fact.

Rep. Carol Devine Miller (R-WV) disclosed four March 2025 transactions, each 522 days late: Pfizer Inc (PFE), Quest Diagnostics Inc (DGX), Target Corp (TGT), and U.S. Bancorp (USB).

Rep. Derek Tran (D-CA) disclosed a sale of Litecoin (a cryptocurrency) from July 28, 2025, arriving 382 days late.

Rep. Shri Thanedar (D-MI) disclosed two late transactions: MicroStrategy Inc (MSTR) from October 2025 (297 days late) and Apple Inc (AAPL) from January 2026 (217 days late).

All-time: Across 22,158 total STOCK Act filings in our database, 2,700 — or 12.2% — were submitted past the 45-day deadline. The members with the most all-time late filings are Rep. Sheri Biggs (171), Rep. Julia Letlow (136), Rep. Valerie Hoyle (114), Sen. Thomas H. Tuberville (108), and Rep. Alan Armstrong (96). Late disclosure is a timing compliance matter, not an assertion of any other wrongdoing.

The Fine Print

Data derived from public STOCK Act disclosures. Disclosure date is not the trade date (filings lag 30-45 days). Dollar figures are disclosed ranges, not exact amounts. Conflict-of-interest flags are heuristic "potential overlaps," not assertions of wrongdoing. Not investment advice.